Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with … Z Li, H Huang, Y Li, X Jiang, P Chen, S Arnovitz, MD Radmacher, ... Blood, The Journal of the American Society of Hematology 119 (10), 2314-2324, 2012 | 201 | 2012 |
Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia X Jiang, H Huang, Z Li, Y Li, X Wang, S Gurbuxani, P Chen, C He, D You, ... Cancer cell 22 (4), 524-535, 2012 | 200 | 2012 |
MicroRNAs in cancer biology and therapy: current status and perspectives C Price, J Chen Genes & diseases 1 (1), 53-63, 2014 | 163 | 2014 |
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia X Jiang, H Huang, Z Li, C He, Y Li, P Chen, S Gurbuxani, S Arnovitz, ... Proceedings of the National Academy of Sciences 109 (47), 19397-19402, 2012 | 143 | 2012 |
miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia–rearranged leukemia P Chen, C Price, Z Li, Y Li, D Cao, A Wiley, C He, S Gurbuxani, ... Proceedings of the National Academy of Sciences 110 (28), 11511-11516, 2013 | 121 | 2013 |
Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma A Magen, P Hamon, N Fiaschi, BY Soong, MD Park, R Mattiuz, E Humblin, ... Nature medicine 29 (6), 1389-1399, 2023 | 62 | 2023 |
Genome-wide interrogation of human cancers identifies EGLN1 dependency in clear cell ovarian cancers C Price, S Gill, ZV Ho, SM Davidson, E Merkel, JM McFarland, L Leung, ... Cancer research 79 (10), 2564-2579, 2019 | 34 | 2019 |
Crosstalk between DNA and histones: Tet’s new role in embryonic stem cells X Sui, C Price, Z Li, J Chen Current genomics 13 (8), 603-608, 2012 | 22 | 2012 |
Spatial analysis of human lung cancer reveals organized immune hubs enriched for stem-like CD8 T cells and associated with immunotherapy response JH Chen, LT Nieman, M Spurrell, V Jorgji, P Richieri, KH Xu, R Madhu, ... BioRxiv, 2023.04. 04.535379, 2023 | 14 | 2023 |
Intratumoral mregDC and CXCL13 T helper niches enable local differentiation of CD8 T cells following PD-1 blockade A Magen, P Hamon, N Fiaschi, L Troncoso, E Humblin, D D’souza, ... BioRxiv, 2022.06. 22.497216, 2022 | 8 | 2022 |
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy JH Chen, LT Nieman, M Spurrell, V Jorgji, L Elmelech, P Richieri, KH Xu, ... Nature Immunology, 1-15, 2024 | 2 | 2024 |
A single-cell spatially resolved map of colorectal cancer identifies novel spatial relationships between cancer cells and the microenvironment C Price, JH Chen, K Pelka, S Chao, M Therrien, T Wiggin, N Fernandez, ... Cancer Research 82 (12_Supplement), 2030-2030, 2022 | 2 | 2022 |
920 A single-cell spatially resolved MERFISH map of the colorectal tumor immune microenvironment C Price, J Chen, K Pelka, S Chao, J He, G Boland, G Emanuel, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 2 | 2021 |
MLL-Rearrangements Result in Upregulation of Mir-9 and Subsequent Inhibition of the Tumor Suppressor TGFBI CO Price, P Chen, Z Li, Y Li, A Wiley, C He, H Huang, X Jiang, S Arnovitz, ... Blood 118 (21), 2453, 2011 | 1 | 2011 |
Abstract LB331: Integrating multiple spatial transcriptomic and proteomic technologies to generate a cancer atlas to understand the tumor microenvironment C Price, K Nishimura, S Bandyopadhyay, D Borger, R Weiner Cancer Research 84 (7_Supplement), LB331-LB331, 2024 | | 2024 |
Spatial organization and cellular composition of immunity hubs in human colorectal cancer MG Palshikar, M Spurrell, J Demaray, H Chen, S Engels, R Madhu, ... Cancer Research 84 (6_Supplement), 5492-5492, 2024 | | 2024 |
Integrating spatial transcriptomics count data with Crescendo improves visualization and detection of spatial gene patterns N Millard, JH Chen, MG Palshikar, K Pelka, M Spurrell, C Price, J He, ... bioRxiv, 2024.03. 07.583997, 2024 | | 2024 |
222-H A single-cell spatial cancer atlas of solid malignancies C Price, K Nishimura, M Zhou, S Bandyopadhyay, R Weiner, D Borger Journal for ImmunoTherapy of Cancer 11 (Suppl 2), 2023 | | 2023 |
Targeting egln1 in cancer W Hahn, F Vazquez, C Price US Patent App. 17/275,061, 2022 | | 2022 |
Understanding HIF1A-mediated therapy in clear cell ovarian cancer. C Price, S Gill, ZV Ho, SM Davidson, E Merkel, JM McFarland, L Leung, ... CLINICAL CANCER RESEARCH 26 (13), 73-73, 2020 | | 2020 |